About Us
The Name
- Pronounced as “Noos - Q”.
- In Greek classical philosophy, “nous” is the faculty of the human mind necessary for the understanding of what is true. “NousQ” symbolises vision, mastery and heart.
- The “Q” is our relentless quest to meet the real needs of patients the world over.
Our Company
- Introductory commercialisation in Singapore - June 2026
- NousQ Pte Ltd is a Singapore start-up company founded in July 2021 to design, develop, manufacture and commercialise best-in-class innovative medical technology and devices for patients.
- NousQ aims to provide patient-centric medical solutions that patients really want and need
- Prior to that, CLiKX®️ was developed with over SGD 5 million in competitive research grant funding from Agency for Science Technology and Research (A*STAR) and National Research Foundation of Singapore. Host institutions were the National University of Singapore and SG Innovate.
- We aspire not only to innovate to optimize healthcare delivery for existing patients, but also to meet the needs of the many millions of patients who cannot access care currently.
- With valued stakeholders we partner for a robust and sustainable enterprise, we want to give hope to patients all over the world.
- The company closed its Seed Round in late 2021 and its Pre Series A Round in early 2025.
- The company is currently inviting expression of interest for its Series A round on the back of successful pivotal clinical trials.
Our Logo
- The 3 circles represent our team, our patients and our partners.
- The 3 circles are also a nod to our first product CLiKX®️, the ventilation tube and the ear drum.
- The short line shouts, “All together now!”
Our Quality
- Therapeutic Goods Administration (TGA) approval in Australia - June 2026
- Health Sciences Authority (HSA) approval in Singapore - May 2026
- Awarded ISO 13485:2016 on establishment of our Quality Management System
- Scope includes; Design, Development, Manufacture, Distribution of ENT surgical instrument with sterile shaft
